Friday, July 13, 2012

Last drugs standing: Key Alzheimer results coming


—Bapineuzumab (bap-ih-NOOZ-uh-mab), by Pfizer Inc. and Johnson & Johnson’s Janssen Alzheimer Immunotherapy unit.
—Solanezumab (sol-ah-NAYZ-uh-mab), by Eli Lilly & Co.
—Gammagard, by Baxter International Inc.

No comments:

Post a Comment